相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
Torsten O. Nielsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality
Ioannis A. Vathiotis et al.
NPJ PRECISION ONCOLOGY (2021)
Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens
Allison L. Hunt et al.
ISCIENCE (2021)
Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients
Yue Zhao et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2020)
Prognostic gene expression signature for high-grade serous ovarian cancer
J. Millstein et al.
ANNALS OF ONCOLOGY (2020)
CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer
Justin W. Gorski et al.
DIAGNOSTICS (2020)
Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma
Angela M. Y. Chan et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2020)
Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma
Hong-Tao Li et al.
ONCOLOGY LETTERS (2020)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Lauren C. Peres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Lauren C. Peres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
Peter F. Rambau et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2018)
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
Dale W. Garsed et al.
CLINICAL CANCER RESEARCH (2018)
A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2
Kristian Jensen et al.
MODERN PATHOLOGY (2017)
A comparison of p53 and WT1 immunohistochemical expression patterns in tubo-ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy
Laura Casey et al.
HISTOPATHOLOGY (2017)
The prognostic value of Ki67 in ovarian high-grade serous carcinoma: an 11-year cohort study of Chinese patients
Ming Chen et al.
ONCOTARGET (2017)
Correlation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancer
Katarzyna Nowinska et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
On the Dependency of Cellular Protein Levels on mRNA Abundance
Yansheng Liu et al.
CELL (2016)
A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression
Zheng Feng et al.
SCIENTIFIC REPORTS (2016)
Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction
Aline Talhouk et al.
PLOS ONE (2016)
Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
Martin Kobel et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study
Aladim Gomes Lameira et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2014)
RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer
Õsa Ehlén et al.
Translational Oncology (2014)
Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases
Lik Hang Lee et al.
SCIENTIFIC REPORTS (2014)
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
Bjorn Nodin et al.
DIAGNOSTIC PATHOLOGY (2012)
Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma
Amy B. Bromley et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2012)
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
Kelly L. Bolton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma
Youn Soo Lee et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma
K. Miller et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma
Anais Malpica et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Nature of cell kinetics in psoriatic epidermis
Furuzan K. Doger et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
The roles of the MCM, ORC, and Cdc6 proteins in determining the replication competence of chromatin in quiescent cells
MA Madine et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
分享论文
